Read + Share
Hamidi S, Iyer P, Dadu R, Gule-Monroe M, et al. Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E)
Mutated Anaplastic Thyroid Carcinoma. Thyroid 2024 Jan 16. doi: 10.1089/thy.2023.0573.
PMID: 38226606
|
 |
|
Hamidi S, Iyer P, Dadu R, Gule-Monroe M, et al. Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E)
Mutated Anaplastic Thyroid Carcinoma. Thyroid 2024 Jan 16. doi: 10.1089/thy.2023.0573.
PMID: 38226606
|
|
|
|